ALLERCLEAR dexchlorpheniramine maleate 2 mg tablets blister pack

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

dexchlorpheniramine maleate, Quantity: 2 mg

Commercializzato da:

AFT Pharmaceuticals Pty Ltd

Forma farmaceutica:

Tablet, uncoated

Composizione:

Excipient Ingredients: maize starch; magnesium stearate; pregelatinised maize starch; lactose

Via di somministrazione:

Oral

Confezione:

20s and 40s

Tipo di ricetta:

(S3) Pharmacist Only Medicine

Indicazioni terapeutiche:

ALLERCLEAR is indicated for symptomatic treatment of perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild uncomplicated allergic skin manifestations of urticaria and,angioedema. ALLERCLEAR may relieve itching due to skin conditions such as allergic eczema, pruritus ani, pruritus vulvae, atopic dermatitis, contact dermatitis, insect bites, dermographism and medicine reactions, including serum sickness.

Dettagli prodotto:

Visual Identification: White to off white, round, flat faced beveled edge tablets, score on one side and plain on other side; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Stato dell'autorizzazione:

Registered

Data dell'autorizzazione:

2020-11-12